The FDA has approved Nucala (mepolizumab) for the add-on maintenance treatment of patients with inadequately controlled eosinophilic COPD.

AACE released clinical guidelines on the diagnosis, management, and surveillance of tumors related to multiple endocrine neoplasia type 1.

COVID-19 vaccination during pregnancy was not associated with spontaneous abortion, regardless of dose number or manufacturer.

Maternal vaccination and, to a lesser extent, nirsevimab appear to significantly reduce RSV-related hospitalizations in infants.

Mucus plugs in former smokers with COPD were associated with faster decline in FEV1 compared with no or resolved plugs.

Pediatric community-acquired pneumonia severity can be predicted accurately with 7 factors based on a new model.

RFK Jr talked about stopping NIH-funded researchers from publishing in The Lancet, New England Journal of Medicine, and JAMA.

Remdesivir was associated with a significant survival benefit and reduced risk for rehospitalization among inpatients with COVID-19 infection.

Long-term health care utilization is greater among patients with COPD who have tested positive for COVID-19 and are unvaccinated.

Topline results were announced from two phase 3 trials evaluating itepekimab in former smokers with inadequately controlled COPD.

An AAAAI report says climate change has affected the prevalence and morbidity of allergic rhinitis, nonallergic rhinitis, and chronic rhinosinusitis.

Pediatric patients exhibited high risk for severe avian influenza A/H5N1, suggesting clinical therapeutic and vaccine trials should be prioritized in this population.